These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 1324161

  • 1. Transforming growth factor-beta modulates receptor binding of calciotropic hormones and G protein-mediated adenylate cyclase responses in osteoblast-like cells.
    Schneider HG, Michelangeli VP, Frampton RJ, Grogan JL, Ikeda K, Martin TJ, Findlay DM.
    Endocrinology; 1992 Sep; 131(3):1383-9. PubMed ID: 1324161
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
    Lajeunesse D, Moreau R, Hobbs W, Qui W, Lafond J, Guggino SE.
    J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor and interleukin 1 inhibit parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by down-regulating parathyroid hormone receptors.
    Katz MS, Gutierrez GE, Mundy GR, Hymer TK, Caulfield MP, McKee RL.
    J Cell Physiol; 1992 Oct; 153(1):206-13. PubMed ID: 1325978
    [Abstract] [Full Text] [Related]

  • 6. Specific down-regulation of parathyroid hormone (PTH) receptors and responses to PTH by tumour necrosis factor alpha and retinoic acid in UMR 106-06 osteoblast-like osteosarcoma cells.
    Schneider HG, Allan EH, Moseley JM, Martin TJ, Findlay DM.
    Biochem J; 1991 Dec 01; 280 ( Pt 2)(Pt 2):451-7. PubMed ID: 1660713
    [Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor alpha modulates parathyroid hormone action in UMR-106-01 osteoblastic cells.
    Hanevold CD, Yamaguchi DT, Jordan SC.
    J Bone Miner Res; 1993 Oct 01; 8(10):1191-200. PubMed ID: 8256656
    [Abstract] [Full Text] [Related]

  • 8. Parathyroid hormone desensitization in renal membranes of vitamin D-deficient rats is associated with a postreceptor defect.
    Mitchell J, Tenenhouse A, Warner M, Goltzman D.
    Endocrinology; 1988 May 01; 122(5):1834-41. PubMed ID: 2834176
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of transforming growth factor beta on parathyroid hormone receptor binding and cAMP formation in rat osteosarcoma cells.
    Seitz PK, Zhu BT, Cooper CW.
    J Bone Miner Res; 1992 May 01; 7(5):541-6. PubMed ID: 1319667
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by transforming growth factor alpha and epidermal growth factor.
    Gutierrez GE, Mundy GR, Derynck R, Hewlett EL, Katz MS.
    J Biol Chem; 1987 Nov 25; 262(33):15845-50. PubMed ID: 3500168
    [Abstract] [Full Text] [Related]

  • 12. Inactivation of pertussis toxin-sensitive guanyl nucleotide-binding proteins increase parathyroid hormone receptors and reverse agonist-induced receptor down-regulation in ROS 17/2.8 cells.
    Abou-Samra AB, Jueppner H, Potts JT, Segre GV.
    Endocrinology; 1989 Nov 25; 125(5):2594-9. PubMed ID: 2477233
    [Abstract] [Full Text] [Related]

  • 13. Biochemical and morphological characterization of parathyroid hormone receptor binding to the rat osteosarcoma cell line UMR-106.
    Mitchell J, Rouleau MF, Goltzman D.
    Endocrinology; 1990 May 25; 126(5):2327-35. PubMed ID: 2158423
    [Abstract] [Full Text] [Related]

  • 14. 1,25-dihydroxyvitamin D reduces parathyroid hormone receptor number in ROS 17/2.8 cells and prevents the glucocorticoid-induced increase in these receptors: relationship to adenylate cyclase activation.
    Titus L, Jackson E, Nanes MS, Rubin JE, Catherwood BD.
    J Bone Miner Res; 1991 Jun 25; 6(6):631-7. PubMed ID: 1653516
    [Abstract] [Full Text] [Related]

  • 15. Effects of differentiation and transforming growth factor beta 1 on PTH/PTHrP receptor mRNA levels in MC3T3-E1 cells.
    McCauley LK, Koh AJ, Beecher CA, Cui Y, Decker JD, Franceschi RT.
    J Bone Miner Res; 1995 Aug 25; 10(8):1243-55. PubMed ID: 8585429
    [Abstract] [Full Text] [Related]

  • 16. Glucocorticoids increase parathyroid hormone receptors in rat osteoblastic osteosarcoma cells (ROS 17/2).
    Yamamoto I, Potts JT, Segre GV.
    J Bone Miner Res; 1988 Dec 25; 3(6):707-12. PubMed ID: 2855194
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D and dexamethasone inversely regulate parathyroid hormone-induced regulator of G protein signaling-2 expression in osteoblast-like cells.
    Hömme M, Schmitt CP, Himmele R, Hoffmann GF, Mehls O, Schaefer F.
    Endocrinology; 2003 Jun 25; 144(6):2496-504. PubMed ID: 12746312
    [Abstract] [Full Text] [Related]

  • 18. Dexamethasone effects on beta-adrenergic receptors and adenylate cyclase regulatory proteins Gs and Gi in ROS 17/2.8 cells.
    Rodan SB, Rodan GA.
    Endocrinology; 1986 Jun 25; 118(6):2510-8. PubMed ID: 3009162
    [Abstract] [Full Text] [Related]

  • 19. Adenylate cyclase of osteoblast-like cells from rat osteosarcoma is stimulated by calcitonin as well as parathyroid hormone.
    Gutierrez GE, Mundy GR, Katz MS.
    Endocrinology; 1984 Dec 25; 115(6):2342-6. PubMed ID: 6594230
    [Abstract] [Full Text] [Related]

  • 20. Cyclic adenosine 3',5'-monophosphate (cAMP)-dependent and cAMP-independent regulation of parathyroid hormone receptors on UMR 106-01 osteoblastic osteosarcoma cells.
    Abou-Samra AB, Zajac JD, Schiffer-Alberts D, Skurat R, Kearns A, Segre GV, Bringhurst FR.
    Endocrinology; 1991 Nov 25; 129(5):2547-54. PubMed ID: 1718728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.